AstraZeneca drug Imfinzi fails as monotherapy for type of lung cancer
Imfinzi, in a phase-III trial called 'Pearl', failed in patients whose tumour cells express high levels of PD-L1, or in a subgroup…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.